No evidence of resistance to itraconazole in a prospective real-world trial of dermatomycosis in India

BACKGROUND: The prevalence of superficial fungal infections in India is believed to have increased substantially in the past decade. We evaluated the treatment outcomes and risk factors associated with clinical response to a treatment course of itraconazole for the management of dermatomycosis in In...

Descripción completa

Detalles Bibliográficos
Autores principales: Handa, S., Villasis-Keever, A., Shenoy, M., Anandan, S., Bhrushundi, M., Garodia, N., Fife, D., De Doncker, P., Shalayda, K., Hu, P., Fonseca, S., Cure-bolt, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928099/
https://www.ncbi.nlm.nih.gov/pubmed/36787305
http://dx.doi.org/10.1371/journal.pone.0281514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928099/
https://www.ncbi.nlm.nih.gov/pubmed/36787305
http://dx.doi.org/10.1371/journal.pone.0281514

Ejemplares similares